|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.35 USD | +9.42% |
|
+13.08% | +2.27% |
Company Valuation: Beam Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,327 | 2,692 | 2,159 | 1,974 | 2,736 | 2,579 | - | - |
| Change | - | -49.47% | -19.78% | -8.58% | 38.6% | -5.73% | - | - |
| Enterprise Value (EV) 1 | 4,367 | 1,613 | 969.4 | 1,974 | 2,441 | 1,724 | 1,407 | 1,787 |
| Change | - | -63.05% | -39.92% | 103.62% | 23.66% | -29.35% | -18.4% | 27.02% |
| P/E | -13.8x | -9.47x | -15.8x | -5.41x | -34.2x | -5.92x | -5.6x | -5.93x |
| PBR | 6.19x | 3.66x | 2.14x | 2.83x | 2.28x | 3.18x | 2.85x | 4.33x |
| PEG | - | 0.3x | 0.3x | -0x | 0.4x | -0x | -1x | 1.06x |
| Capitalization / Revenue | 103x | 44.2x | 5.72x | 31.1x | 19.6x | 33.4x | 28.1x | 14.6x |
| EV / Revenue | 84.2x | 26.5x | 2.57x | 31.1x | 17.5x | 22.4x | 15.3x | 10.1x |
| EV / EBITDA | -11.3x | -4.97x | -6.2x | -5.01x | -6.75x | -3.68x | -2.75x | -3.66x |
| EV / EBIT | -11.1x | -4.77x | -5.49x | -4.75x | -6.36x | -3.54x | -2.57x | -3.15x |
| EV / FCF | -38.6x | -61.1x | -5.3x | -5.54x | -6.78x | -4.07x | -3.34x | -4.79x |
| FCF Yield | -2.59% | -1.64% | -18.9% | -18% | -14.8% | -24.6% | -30% | -20.9% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -5.77 | -4.13 | -1.72 | -4.58 | -0.81 | -4.379 | -4.624 | -4.366 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 51.84 | 60.92 | 377.7 | 63.52 | 139.7 | 77.14 | 91.75 | 177 |
| EBITDA 1 | -385 | -324.3 | -156.5 | -393.6 | -361.4 | -468.2 | -511 | -487.7 |
| EBIT 1 | -392.5 | -338.5 | -176.5 | -415.6 | -383.7 | -487.8 | -546.6 | -568.1 |
| Net income 1 | -370.6 | -289.1 | -132.5 | -376.7 | -79.99 | -459.1 | -529.7 | -531.1 |
| Net Debt 1 | -960.4 | -1,078 | -1,190 | - | -294.9 | -854.5 | -1,172 | -791.7 |
| Reference price 2 | 79.69 | 39.11 | 27.22 | 24.80 | 27.72 | 25.91 | 25.91 | 25.91 |
| Nbr of stocks (in thousands) | 66,849 | 68,821 | 79,326 | 79,592 | 98,693 | 99,537 | - | - |
| Announcement Date | 2/28/22 | 2/28/23 | 2/27/24 | 2/25/25 | 2/24/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.96x | 21.86x | -3.64x | -.--% | 2.58B | |
| 32.9x | 5.88x | 17.49x | 0.97% | 48.22B | |
| -22.77x | 340.62x | -20.81x | -.--% | 38.79B | |
| 29.98x | 3x | 12.95x | -.--% | 38.41B | |
| 46.6x | 4.72x | 30.74x | -.--% | 34.88B | |
| 27.72x | 8.03x | 20.18x | 0.42% | 29.19B | |
| 32.6x | 5.33x | 24.22x | -.--% | 16B | |
| 22.53x | 1.98x | 8.57x | 1.17% | 13.53B | |
| 24.75x | 1.81x | 11.1x | -.--% | 12.22B | |
| Average | 20.93x | 43.69x | 11.20x | 0.29% | 25.98B | |
| Weighted average by Cap. | 23.11x | 60.73x | 12.08x | 0.32% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BEAM Stock
- Valuation Beam Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
